| scholarly article | Q13442814 |
| P50 | author | Gary Hardiman | Q42705073 |
| Takahiro Ito | Q64819809 | ||
| Takaaki Konuma | Q79233983 | ||
| David Rizzieri | Q92624494 | ||
| P2093 | author name string | Claire S Koechlein | |
| Jeevisha Bajaj | |||
| Nikki K Lytle | |||
| Roman Sasik | |||
| Tannishtha Reya | |||
| Hyog Young Kwon | |||
| Charles Chuah | |||
| Joi Weeks | |||
| Allen Blevins | |||
| Vivian G Oehler | |||
| P2860 | cites work | SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins | Q24308610 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens | Q24557431 | ||
| Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia | Q24597256 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Regulation of myeloid leukaemia by the cell-fate determinant Musashi | Q24634359 | ||
| OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes | Q24680419 | ||
| Tetraspanin functions and associated microdomains | Q28284176 | ||
| MLL translocations, histone modifications and leukaemia stem-cell development | Q29615368 | ||
| Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches | Q29617460 | ||
| Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells | Q29618944 | ||
| In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment | Q30484167 | ||
| Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia | Q30608477 | ||
| AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias | Q34212654 | ||
| Anthracycline dose intensification in acute myeloid leukemia | Q34612121 | ||
| In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model | Q34704145 | ||
| Microarray truths and consequences. | Q35854939 | ||
| Tetraspanin microdomains in immune cell signalling and malignant disease. | Q35923947 | ||
| A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia | Q35953355 | ||
| PBX3 is an important cofactor of HOXA9 in leukemogenesis | Q36628305 | ||
| CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia | Q36891005 | ||
| Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation | Q36920398 | ||
| HOXA9 is required for survival in human MLL-rearranged acute leukemias | Q37129652 | ||
| Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes | Q37169475 | ||
| Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. | Q37185272 | ||
| Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. | Q37234638 | ||
| Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. | Q37234641 | ||
| Current treatment of acute myeloid leukemia | Q38046723 | ||
| Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells | Q39903574 | ||
| The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation | Q39943574 | ||
| CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice | Q40566210 | ||
| Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia | Q40571705 | ||
| Association of TM4SF proteins with integrins: relevance to cancer | Q41009699 | ||
| Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus | Q42521348 | ||
| The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. | Q42723875 | ||
| Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Q46799049 | ||
| CXCR4 is a prognostic marker in acute myelogenous leukemia. | Q53607339 | ||
| Appearance of new tetraspanin genes during vertebrate evolution. | Q55048780 | ||
| Tetraspanins and malignancy | Q58044902 | ||
| MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia | Q61830011 | ||
| Identification of a gene expression signature associated with pediatric AML prognosis | Q73372374 | ||
| SnapShot: Acute myeloid leukemia | Q85444163 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 152-164 | |
| P577 | publication date | 2015-07-23 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia | |
| P478 | volume | 17 |
| Q103001382 | A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia |
| Q102141736 | AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth |
| Q91106536 | CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth |
| Q38727999 | CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia |
| Q52571378 | Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. |
| Q30252566 | Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells |
| Q38813967 | Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance |
| Q93216336 | HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells |
| Q93344389 | IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation |
| Q30803684 | Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma |
| Q36611010 | MSI2 is required for maintaining activated myelodysplastic syndrome stem cells |
| Q90400285 | MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial-mesenchymal transition |
| Q41927505 | MUSASHI-2 duels in myelodysplastic syndromes |
| Q39112430 | Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets |
| Q37264305 | Musashi mediates translational repression of the Drosophila hypoxia inducible factor. |
| Q41459688 | Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3. |
| Q39247132 | RNA editing-dependent epitranscriptome diversity in cancer stem cells |
| Q64887305 | Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. |
| Q39441272 | Stem Cells, Cancer, and MUSASHI in Blood and Guts |
| Q91518791 | Stem cell fate in cancer growth, progression and therapy resistance |
| Q48016360 | Structural Insight into the Recognition of r(UAG) by Musashi-1 RBD2, and Construction of a Model of Musashi-1 RBD1-2 Bound to the Minimum Target RNA. |
| Q90589724 | Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation |
| Q47329099 | Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia |
Search more.